JP Morgan Maintains Neutral on Incyte, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 61.6%

Neg 0% Neu 0% Pos 61.6%

JP Morgan analyst Jessica Fye maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price target from $105 to $110.